| Value | ₹3.64 Cr |
|---|---|
| Execution period | 30 Days |
NSE filing, NSE: RBS. Summary written from the filing by ALFA Finder's alert engine.
Ramdevbaba Solvent Ltd: key numbers
- Share price
- ₹72.00
- Market cap
- ₹172.8 Cr
- Revenue (annual)
- ₹823.3 Cr
- Net profit (annual)
- ₹11.43 Cr
- P/E (TTM)
- 15.1×Sector 38.3×
- Promoter holding
- 64.39%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ramdevbaba Solvent Ltd
All →Ramdevbaba Solvent Board Meeting Date
Ramdevbaba Solvent Limited intimates a board meeting on 4 November 2026 to consider half-yearly unaudited results for September 2026 and an interim dividend. Trading window closes from 1 October 2026.
Ramdevbaba Solvent Other Announcement
Ramdevbaba Solvent filed a non-applicability intimation for its quarterly corporate governance report. As an NSE SME listed entity, the SEBI LODR governance provisions do not apply to it.
Ramdevbaba Solvent Business Update
Ramdevbaba Solvent Limited received multiple achievement awards from The Solvent Extractors’ Association of India. The honors recognize its performance as a leading processor and producer of rice bran oil.
Ramdevbaba Solvent Annual General Meeting
Ramdevbaba Solvent Limited conducted its 18th Annual General Meeting on 23rd September, 2026, via video conferencing to discuss routine business resolutions.
Ramdevbaba Solvent Annual Report
Ramdevbaba Solvent Limited has submitted its Annual Report for the financial year 2025-26. The 18th Annual General Meeting is scheduled for September 23, 2026.
Ramdevbaba Solvent Annual General Meeting
Ramdevbaba Solvent Limited approved its Annual Report, scheduled its 18th Annual General Meeting for September 23, 2026, and adopted the Cost Audit Report.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr